|
|
|
| home > white papers > Conveying Medical Guidance in Clinical Trials – A Survey - Europital Medical Consultancy |
|
|
 WHITE PAPERS |
|
Europital Medical Consultancy
|
|
Conveying Medical Guidance in Clinical Trials – A Survey
|
|
With the incremental demand for proactive safety surveillance throughout
the conduct of clinical trials, the role of Medical Management is at
the fore in ensuring the safety and wellbeing of the participants. The
complex responsibilities of a Medical Monitor (MM) starts from the
design and development phase, through to study close out. Understanding
the principle behind the protocol and the prospective medical solution
the study would deliver forms the bloodline for the MM role. Often, the
MM is the face of contact for both the site personnel and the study team
members with regard to medical, safety and scientific issues within the
project.
When it comes to medical guidance, the communication channel used to
deliver solutions contributes to a large extent in effectively managing
decisive situations. Our previous study on acquiring medical guidance
from an operations team perspective revealed that e-mails were the most
used communication method (see the article, 'Talking Points', in ICT November 2014). In our efforts to further strengthen the mode of medical
guidance delivery, we designed a survey to study the existing trend and
constraints in this communication chain management, as outlined here.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
ERT’s At-Home Cardiac Safety Assessment Ensures Clinical Trial Continuity
PHILADELPHIA – March 30, 2020 – ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a cardiac safety solution that helps biopharmaceutical researchers continue important clinical trials during current global ‘stay home’ mandates. The solution enables clinician-administered ECG readings ─ using ERT’s provisioned, FDA-cleared devices or other investigative site–owned equipment ─ to evaluate the safety of new vaccines and medical treatments from patients’ homes.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trial-Specific Travel Programs as a Patient Retention Tool
For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >> |
|
 |
Industry Events |
 |
Evolution Summit
20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL
The 22nd Evolution Summit is the premium forum bringing leading drug
development executives and solution providers together. As an
invitation-only event, taking place behind closed doors, the Summit
offers an intimate environment for a focused discussion of key new
drivers shaping drug development.
More info >> |
|
|
|
